Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Hello and welcome to the Annual Meeting of Stockholders of Ligand Pharmaceuticals Incorporated. Please note, today's meeting is being recorded. (Operator Instructions)
It is now my pleasure to turn today's meeting over to Charles Berkman, Ligand's General Counsel. The floor is yours.
Welcome to Ligand's annual meeting. I am Charles Berkman, Ligand's General Counsel, and I will act as Chairman and Secretary for this meeting. We are hosting this year's annual meeting in a virtual-only format. If you encounter any technical difficulties accessing or participating in the meeting, please refer to the support link on the virtual meeting website for information on how to reach our support team.
Computershare, represented by Mark Cano, will act as the inspector of elections. Also attending today's meeting are Emma Epes and Robert Singer from Ernst & Young LLP, the company's independent registered public accounting firm.
All stockholders
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |